LobbyingVir Biotechnology lobbying by quarter
Vir Biotechnology VIR's latest lobbying report covers Q2 2026, at $50K. The four quarters Q4 2025–Q3 2026 total $150K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Taxation/Internal Revenue Code.
Vir BiotechnologyVIR
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $150K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $270K | 3 |
| Q1 2023 | $270K | 3 |
| Q2 2023 | $290K | 3 |
| Q3 2023 | $270K | 3 |
| Q4 2023 | $170K | 3 |
| Q1 2024 | $50K | 1 |
| Q2 2024 | $50K | 1 |
| Q3 2024 | $50K | 1 |
| Q4 2024 | $50K | 1 |
| Q1 2025 | $50K | 1 |
| Q2 2025 | $50K | 1 |
| Q3 2025 | $50K | 1 |
| Q4 2025 | $50K | 1 |
| Q1 2026 | $50K | 1 |
| Q2 2026 | $50K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$741.2K · 25 reports
- Taxation$324.5K · 14 reports
- Budget and appropriations$164.2K · 9 reports
- Government issues$164.2K · 9 reports
- Medicare and Medicaid$137K · 5 reports
- Science and technology$137K · 5 reports
- Trade$102K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES25 reports
- SENATE21 reports
- Health & Human Services, Dept of (HHS)20 reports
- Centers For Medicare and Medicaid Services (CMS)5 reports
- Natl Institutes of Health (NIH)5 reports
- Office of Science & Technology Policy (OSTP)5 reports
- Centers For Disease Control & Prevention (CDC)4 reports
- Natl Security Council (NSC)4 reports
- U.S. International Trade Commission (ITC)4 reports
- White House Office4 reports
Firms it paid
| Firm | ||
|---|---|---|
| Forbes-Tate | $890K | 15 quarters |
| In-houseVir Biotechnology | $650K | 5 quarters |
| W Strategies | $230K | 5 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| MICHAEL ALEXANDER WILLIAMS | Legislative Director, Rep. Lucy McBath (2021-2022); Legislative Assistant, Rep. Lucy McBath (2019-2020); Legislative Aide, Sen. Doug Jones (2019); Legislative Correspondent, Sen. Doug Jones (2018-2019) | Q4 2025 |
| ARTHUR DENNIS SIDNEY | LD & Chief Counsel, Rep. Jackson Lee (2008-2009); Chief of staff and chief counsel, Rep. Johnson (2009-2020) | Q1 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Forbes-Tate | $50K |
| 04/19for Q1 | Forbes-Tate | $50K |
| 01/17for Q4 2025 | Forbes-Tate | $50K |
| 25/10/18for Q3 2025 | Forbes-Tate | $50K |
| 25/07/18for Q2 2025 | Forbes-Tate | $50K |
| 25/04/16for Q1 2025 | Forbes-Tate | $50K |
| 25/01/19for Q4 2024 | Forbes-Tate | $50K |
| 24/10/18for Q3 2024 | Forbes-Tate | $50K |
| 24/07/14for Q2 2024 | Forbes-Tate | $50K |
| 24/04/14for Q1 2024 | Forbes-Tate | $50K |
| 24/01/18for Q4 2023 | W Strategies | $30K |
| 24/01/16for Q4 2023 | Forbes-Tate | $70K |
| 23/11/03for Q4 2023 | In-house | $70K |
| 23/10/20for Q3 2023 | W Strategies | $50K |
| 23/10/20for Q3 2023 | In-house | $140K |
| 23/10/17for Q3 2023 | Forbes-Tate | $80K |
| 23/07/20for Q2 2023 | W Strategies | $50K |
| 23/07/20for Q2 2023 | In-house | $160K |
| 23/07/16for Q2 2023 | Forbes-Tate | $80K |
| 23/04/20for Q1 2023 | W Strategies | $50K |